{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:54:50Z","timestamp":1783122890256,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T00:00:00Z","timestamp":1221091200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10549-008-0178-z","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T11:02:24Z","timestamp":1221044544000},"page":"543-549","source":"Crossref","is-referenced-by-count":9,"title":["Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes"],"prefix":"10.1007","volume":"116","author":[{"given":"Bryan P.","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Radovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Flockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet S.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Robarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Storniolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd C.","family":"Skaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Sledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,11]]},"reference":[{"key":"178_CR1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1188\/05.ONF.959-968","volume":"32","author":"JS Carpenter","year":"2005","unstructured":"Carpenter JS (2005) State of the science: hot flashes and cancer. Part 1: definition, scope, impact, physiology, and measurement. Oncol Nurs Forum 32:959\u2013968. doi: 10.1188\/05.ONF.959-968","journal-title":"Oncol Nurs Forum"},{"key":"178_CR2","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc1992","volume":"6","author":"V Stearns","year":"2006","unstructured":"Stearns V, Schneider B, Henry NL, Hayes DF, Flockhart DA (2006) Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. Nat Rev Cancer 6:886\u2013893. doi: 10.1038\/nrc1992","journal-title":"Nat Rev Cancer"},{"key":"178_CR3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","volume":"350","author":"RC Coombes","year":"2004","unstructured":"Coombes RC, Hall E, Gibson LJ et al (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081\u20131092. doi: 10.1056\/NEJMoa040331","journal-title":"N Engl J Med"},{"key":"178_CR4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00001813-200409000-00003","volume":"15","author":"L Morales","year":"2004","unstructured":"Morales L, Neven P, Timmerman D et al (2004) Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anticancer Drugs 15:753\u2013760. doi: 10.1097\/00001813-200409000-00003","journal-title":"Anticancer Drugs"},{"key":"178_CR5","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1200\/JCO.2001.19.10.2596","volume":"19","author":"H Mouridsen","year":"2001","unstructured":"Mouridsen H, Gershanovich M, Sun Y et al (2001) Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol 19:2596\u20132606","journal-title":"J Clin Oncol"},{"key":"178_CR6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1634\/theoncologist.12-1-124","volume":"12","author":"JS Carpenter","year":"2007","unstructured":"Carpenter JS, Storniolo AM, Johns S et al (2007) Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 12:124\u2013135. doi: 10.1634\/theoncologist.12-1-124","journal-title":"Oncologist"},{"key":"178_CR7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdl478","volume":"18","author":"S Loibl","year":"2007","unstructured":"Loibl S, Schwedler K, von Minckwitz G, Strohmeier R, Mehta KM, Kaufmann M (2007) Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients\u2014a double-blind, randomized study. Ann Oncol 18:689\u2013693. doi: 10.1093\/annonc\/mdl478","journal-title":"Ann Oncol"},{"key":"178_CR8","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","volume":"295","author":"HD Nelson","year":"2006","unstructured":"Nelson HD, Vesco KK, Haney E et al (2006) Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 295:2057\u20132071. doi: 10.1001\/jama.295.17.2057","journal-title":"JAMA"},{"key":"178_CR9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","volume":"132","author":"KJ Pandya","year":"2000","unstructured":"Pandya KJ, Raubertas RF, Flynn PJ et al (2000) Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a university of Rochester cancer center community clinical oncology program study. Ann Intern Med 132:788\u2013793","journal-title":"Ann Intern Med"},{"key":"178_CR10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2006.07.5390","volume":"25","author":"CL Loprinzi","year":"2007","unstructured":"Loprinzi CL, Kugler JW, Barton DL et al (2007) Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J Clin Oncol 25:308\u2013312. doi: 10.1200\/JCO.2006.07.5390","journal-title":"J Clin Oncol"},{"key":"178_CR11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00404-006-0132-4","volume":"274","author":"D Cieraad","year":"2006","unstructured":"Cieraad D, Conradt C, Jesinger D, Bakowski M (2006) Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol\/dydrogesterone and conjugated equine oestrogen\/norgestrel on lipids and symptoms. Arch Gynecol Obstet 274:74\u201380. doi: 10.1007\/s00404-006-0132-4","journal-title":"Arch Gynecol Obstet"},{"key":"178_CR12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","volume":"363","author":"L Holmberg","year":"2004","unstructured":"Holmberg L, Anderson H (2004) HABITS (hormonal replacement therapy after breast cancer\u2014is it safe?), a randomised comparison: trial stopped. Lancet 363:453\u2013455. doi: 10.1016\/S0140-6736(04)15493-7","journal-title":"Lancet"},{"key":"178_CR13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/dji005","volume":"97","author":"Y Jin","year":"2005","unstructured":"Jin Y, Desta Z, Stearns V et al (2005) CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 97:30\u201339","journal-title":"J Natl Cancer Inst"},{"key":"178_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00042192-200007010-00002","volume":"7","author":"RR Freedman","year":"2000","unstructured":"Freedman RR (2000) Hot flashes revisited. Menopause 7:3\u20134","journal-title":"Menopause"},{"key":"178_CR15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00006199-200309000-00008","volume":"52","author":"SL Dormire","year":"2003","unstructured":"Dormire SL, Reame NK (2003) Menopausal hot flash frequency changes in response to experimental manipulation of blood glucose. Nurs Res 52:338\u2013343. doi: 10.1097\/00006199-200309000-00008","journal-title":"Nurs Res"},{"key":"178_CR16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.maturitas.2004.01.002","volume":"49","author":"JM Malacara","year":"2004","unstructured":"Malacara JM, Perez-Luque EL, Martinez-Garza S, Sanchez-Marin FJ (2004) The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women. Maturitas 49:163\u2013169. doi: 10.1016\/j.maturitas.2004.01.002","journal-title":"Maturitas"},{"key":"178_CR17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1550-8579(05)80016-6","volume":"2","author":"C Takeo","year":"2005","unstructured":"Takeo C, Negishi E, Nakajima A et al (2005) Association of cytosine-adenine repeat polymorphism of the estrogen receptor-beta gene with menopausal symptoms. Gend Med 2:96\u2013105. doi: 10.1016\/S1550-8579(05)80016-6","journal-title":"Gend Med"},{"key":"178_CR18","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/01.AOG.0000187308.67021.98","volume":"106","author":"K Visvanathan","year":"2005","unstructured":"Visvanathan K, Gallicchio L, Schilling C et al (2005) Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstet Gynecol 106:1372\u20131381","journal-title":"Obstet Gynecol"},{"key":"178_CR19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bjc.6600625","volume":"87","author":"SP Balasubramanian","year":"2002","unstructured":"Balasubramanian SP, Brown NJ, Reed MW (2002) Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer 87:1057\u20131065. doi: 10.1038\/sj.bjc.6600625","journal-title":"Br J Cancer"},{"key":"178_CR20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.11238","volume":"106","author":"P Krippl","year":"2003","unstructured":"Krippl P, Langsenlehner U, Renner W et al (2003) A common 936 C\/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106:468\u2013471. doi: 10.1002\/ijc.11238","journal-title":"Int J Cancer"},{"issue":"1","key":"178_CR21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-007-9755-9","volume":"111","author":"BP Schneider","year":"2008","unstructured":"Schneider BP, Radovich M, Sledge GW et\u00a0al (2008) Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat 111(1):157\u2013163","journal-title":"Breast Cancer Res Treat"},{"key":"178_CR22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/diabetes.53.3.861","volume":"53","author":"D Ray","year":"2004","unstructured":"Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P (2004) Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 53:861\u2013864. doi: 10.2337\/diabetes.53.3.861","journal-title":"Diabetes"},{"key":"178_CR23","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/ndt\/gfi029","volume":"20","author":"AM Summers","year":"2005","unstructured":"Summers AM, Coupes BM, Brennan MF, Ralph SA, Short CD, Brenchley PE (2005) VEGF-460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrol Dial Transplant 20:2427\u20132432. doi: 10.1093\/ndt\/gfi029","journal-title":"Nephrol Dial Transplant"},{"key":"178_CR24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/molehr\/gal024","volume":"12","author":"I Banyasz","year":"2006","unstructured":"Banyasz I, Szabo S, Bokodi G et al (2006) Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia. Mol Hum Reprod 12:233\u2013236. doi: 10.1093\/molehr\/gal024","journal-title":"Mol Hum Reprod"},{"key":"178_CR25","unstructured":"Lemler S, Rufenbarger C, Skaar T et\u00a0al (2005) Creating a DNA bank for pharmacogenomic epidemiology: the Friends for Life study. Breast Cancer Res Treat 94:S153"},{"key":"178_CR26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.GME.0000117061.40493.AB","volume":"11","author":"C Crandall","year":"2004","unstructured":"Crandall C, Petersen L, Ganz PA, Greendale GA (2004) Association of breast cancer and its therapy with menopause-related symptoms. Menopause 11:519\u2013530. doi: 10.1097\/01.GME.0000117061.40493.AB","journal-title":"Menopause"},{"key":"178_CR27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.maturitas.2005.12.001","volume":"54","author":"SR Miller","year":"2006","unstructured":"Miller SR, Gallicchio LM, Lewis LM et al (2006) Association between race and hot flashes in midlife women. Maturitas 54:260\u2013269. doi: 10.1016\/j.maturitas.2005.12.001","journal-title":"Maturitas"},{"key":"178_CR28","doi-asserted-by":"crossref","unstructured":"Appling S, Paez K, Allen J (2007) Ethnicity and vasomotor symptoms in postmenopausal women. [Comparative Study. Journal Article. Research Support, N.I.H., Extramural]. J Womens Health 16(8):1130\u20131138","DOI":"10.1089\/jwh.2006.0033"},{"key":"178_CR29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/154099903766651586","volume":"12","author":"MK Whiteman","year":"2003","unstructured":"Whiteman MK, Staropoli CA, Benedict JC, Borgeest C, Flaws JA (2003) Risk factors for hot flashes in midlife women. J Womens Health (Larchmt) 12:459\u2013472. doi: 10.1089\/154099903766651586","journal-title":"J Womens Health (Larchmt)"},{"key":"178_CR30","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/01.AOG.0000143891.79482.ee","volume":"104","author":"JS Carpenter","year":"2004","unstructured":"Carpenter JS, Monahan PO, Azzouz F (2004) Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Obstet Gynecol 104:1322\u20131326","journal-title":"Obstet Gynecol"},{"key":"178_CR31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/01.psy.0000149255.04806.07","volume":"67","author":"RC Thurston","year":"2005","unstructured":"Thurston RC, Blumenthal JA, Babyak MA, Sherwood A (2005) Emotional antecedents of hot flashes during daily life. Psychosom Med 67:137\u2013146. doi: 10.1097\/01.psy.0000149255.04806.07","journal-title":"Psychosom Med"},{"key":"178_CR32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm1005-1047","volume":"11","author":"MA Esteban","year":"2005","unstructured":"Esteban MA, Maxwell PH (2005) HIF, a missing link between metabolism and cancer. Nat Med 11:1047\u20131048. doi: 10.1038\/nm1005-1047","journal-title":"Nat Med"},{"key":"178_CR33","first-page":"E1016","volume":"272","author":"J Shi","year":"1997","unstructured":"Shi J, Simpkins JW (1997) 17 \u03b2-estradiol modulation of glucose transporter 1 (GLUT 1) expression in blood-brain barrier. Am J Physiol: Endocrinol Metab 272:E1016\u2013E1022","journal-title":"Am J Physiol: Endocrinol Metab"},{"key":"178_CR34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2174\/0929867033457746","volume":"10","author":"B Brune","year":"2003","unstructured":"Brune B, Zhou J (2003) The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1 alpha (HIF-1 alpha). Curr Med Chem 10:845\u2013855. doi: 10.2174\/0929867033457746","journal-title":"Curr Med Chem"},{"key":"178_CR35","first-page":"253","volume":"45","author":"RA Greene","year":"2000","unstructured":"Greene RA (2000) Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer\u2019s disease. Int J Fertil Womens Med 45:253\u2013257","journal-title":"Int J Fertil Womens Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0178-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-008-0178-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-008-0178-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:29:01Z","timestamp":1559233741000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-008-0178-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,11]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1007\/s10549-008-0178-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,11]]}}}